---
document_datetime: 2025-02-12 10:37:39
document_pages: 17
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/duloxetine-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: duloxetine-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 7.9073901
conversion_datetime: 2025-12-28 15:36:39.118483
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Duloxetine Viatris

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                           | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| T/0038               | Transfer of Marketing Authorisation                                                             | 13/01/2025                          | 07/02/2025                                  | SmPC, Labelling and PL           |           |
| IAIN/0037            | A.2.a - Administrative change - Change in the (invented) name of the medicinal product for CAPs | 26/11/2024                          | 28/01/2025                                  | SmPC, Labelling and PL           |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0036   | 4.8 of the SmPC to amend the warning about serotoninergic syndrome and to add the information about the neuroleptic malignant syndrome (NMS), as well as to add stress cardiomyopathy (Takotsubo cartiomyopathy) as an undesirable effect with frequency 'not known'. The package leaflet (PL) has been updated accordingly. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by                             | 23/10/2024   | 28/01/2025   | SmPC, Labelling and PL   | To update sections 4.4 and the MAH   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|--------------------------------------|
| N/0034    | Minor change in labelling or package leaflet not (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 18/06/2024   | 28/01/2025   | PL                       | connected with the SPC               |
|           | This was an application for a group of variations. B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - | 08/11/2023   | n/a          |                          | IA/0033/G                            |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| New certificate for a starting material/reagent/intermediate/or new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. TSE New certificate for a starting material/reagent/intermediate/or new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. TSE New certificate for a starting material/reagent/intermediate/or new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. TSE New certificate for a starting material/reagent/intermediate/or new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. TSE New certificate for a starting material/reagent/intermediate/or new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. TSE New certificate for a starting material/reagent/intermediate/or new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. TSE New certificate for a starting   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

| new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. New certificate for a material/reagent/intermediate/or new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. New certificate for a material/reagent/intermediate/or new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. New certificate for a material/reagent/intermediate/or new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. New certificate for a material/reagent/intermediate/or new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. New certificate for a material/reagent/intermediate/or new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. New certificate for a material/reagent/intermediate/or   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                   | 24/08/2023   | 28/01/2025   | PL                     | N/0032          |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|-----------------|
| IA/0031/G   | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer | 31/08/2022   | n/a          |                        |                 |
| N/0030      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                   | 22/04/2022   | 28/01/2025   | PL                     |                 |
| WS/2214     | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                        | 10/03/2022   | n/a          |                        |                 |
| T/0028      | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                | 15/09/2021   | 19/10/2021   | SmPC, Labelling and PL |                 |
| IAIN/0027/G | This was an application for a group of variations. Replacement or addition of a manufacturer importation and/or batch release                                                                                                                                                                                                                                                      | 20/05/2021   | 29/09/2021   | SmPC, Annex II and PL  | responsible for |

<div style=\"page-break-after: always\"></div>

|           | B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing B.III.1.a.4 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Deletion of certificates (in case multiple certificates exist per material) B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved   |            |            |             |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|
| IB/0026   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 01/02/2021 | 29/09/2021 | SmPC and PL |
| IA/0025/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 16/12/2020 | n/a        |             |

<div style=\"page-break-after: always\"></div>

|           | A.7 - Administrative change - Deletion of manufacturing sites B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                         |            |            |                        |                                                                                                                                                                                                                                                                                |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0024   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                    | 29/10/2020 | 29/09/2021 | SmPC and PL            |                                                                                                                                                                                                                                                                                |
| IB/0023   | B.II.f.1.a.1 - Stability of FP - Reduction of the shelf life of the finished product - As packaged for sale                                                                                                                                                                                                                                                                                                                                                                                                       | 06/10/2020 | 29/09/2021 | SmPC and PL            |                                                                                                                                                                                                                                                                                |
| R/0021    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 12/12/2019 | 13/02/2020 | SmPC, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Duloxetine Mylan in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| IB/0022/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO | 18/10/2019 | 13/02/2020 | SmPC and PL            |                                                                                                                                                                                                                                                                                |

<div style=\"page-break-after: always\"></div>

|           | the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |            |            |             |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|
| IB/0020   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 19/09/2019 | 13/02/2020 | SmPC and PL |
| IA/0019/G | This was an application for a group of variations. B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.b.4 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Deletion of certificates (in case multiple certificates exist per material) B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - | 30/08/2019 | n/a        |             |

<div style=\"page-break-after: always\"></div>

|         | material/reagent/intermediate/or excipient from a new or an already approved manufacturer B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |            |            |                        |             |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------|
| N/0018  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 08/05/2019 | 21/10/2019 | PL                     |             |
| IB/0016 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 17/12/2018 | 21/10/2019 | SmPC and PL            |             |
|         | This was an application for a group of variations. B.II.e.1.a.1 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Solid pharmaceutical forms B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished | 10/10/2018 | 21/10/2019 | SmPC, Labelling and PL | IAIN/0015/G |

<div style=\"page-break-after: always\"></div>

| product - Change in the tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in the tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in the tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in the tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in the tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in the tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in the tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in the tablets, ampoules, etc.) the range of the currently   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|             | tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes   |            |            |                        | product - Change   |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------|
| T/0014      | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 25/07/2018 | 03/08/2018 | SmPC, Labelling and PL |                    |
| IB/0013     | B.II.f.1.b.2 - Stability of FP - Extension of the shelf life of the finished product - After first opening (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                  | 27/04/2018 | 03/08/2018 | SmPC, Labelling and PL |                    |
| IA/0012     | B.II.e.1.a.1 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Solid pharmaceutical forms                                                                                                                                                                                                                                                                                                                                                              | 17/03/2017 | n/a        |                        |                    |
| IAIN/0011/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging                                                                                                                                                                                                                                                       | 03/02/2017 | n/a        |                        | site               |

<div style=\"page-break-after: always\"></div>

|           | or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                               |            |     | B.II.b.1.a - Replacement   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------------------------|
| IB/0010/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary for non-sterile medicinal products | 30/11/2016 | n/a | packaging,                 |
| IA/0009/G | This was an application for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished Minor changes to an approved test                                                                                                                                                                                                                              | 28/10/2016 | n/a | product -                  |

<div style=\"page-break-after: always\"></div>

|             | procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |            |            |                        |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| IB/0008     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 21/09/2016 | 23/12/2016 | SmPC, Labelling and PL |
| IAIN/0007/G | This was an application for a group of variations. B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within | 24/08/2016 | 23/12/2016 | SmPC, Labelling and PL |

<div style=\"page-break-after: always\"></div>

|             | the range of the currently approved pack sizes                                                                                                                                                                                                                                                                                                                                                                                  |            |            |                        |                            |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------------|
| IB/0006/G   | This was an application for a group of variations. B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside approved pack sizes | 12/02/2016 | 23/12/2016 | SmPC, Labelling and PL | the range of the currently |
| IA/0005     | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                             | 12/02/2016 | n/a        |                        |                            |
| IG/0647     | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                 | 11/01/2016 | n/a        |                        |                            |
| IB/0003     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                    | 22/12/2015 | 23/12/2016 | SmPC and PL            |                            |
| IAIN/0002/G | This was an application for a group of variations. immediate packaging of the                                                                                                                                                                                                                                                                                                                                                   | 15/12/2015 | 23/12/2016 | SmPC, Labelling and    | B.II.e.1.a.1 - Change in   |

<div style=\"page-break-after: always\"></div>

| finished product - Qualitative composition - Solid pharmaceutical B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change   | PL   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------|

<div style=\"page-break-after: always\"></div>

|             | tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within   |            |     |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IAIN/0001/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 27/07/2015 | n/a |

<div style=\"page-break-after: always\"></div>

| B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging   | site   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|